SpyGlass Pharma, Inc. (SGP) Institutional Ownership and Insiders Activity
SpyGlass Pharma, Inc. (SGP) is widely held by institutional investors, with 55 firms reporting positions valued at approximately $575.89M based on SEC Form 13F filings for the quarter ended June 30, 2026.
Ra Capital Management, L.P. is the largest disclosed holder, reporting approximately $178.55M in SGP holdings in its latest filing.
Institutional Holders
55
Total Reported Value
$575.89M
Largest Holder
Ra Capital Management, L.P.
Largest Position
$178.55M
Insider Transactions (90d)
0
Latest Filing Quarter
Q2 2026
New Institutional Positions
33
Funds Exiting Positions
0
Top Institutional Owners
View allInvestorReported Balance
- Ra Capital Management, L.P.$178.55M
- Nea Management Company, Llc$164.55M
- Sands Capital Alternatives, Llc$55.65M
- Samsara Biocapital, Llc$46.97M
- Blackrock, Inc.$15.84M
Related SGP Institutional Insights:
- SGP 13F Institutional Holders
- SGP Superinvestors
- SGP Institutional Ownership Changes
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- SGP Insider Trading & SEC Form 4 Activity
- SGP Articles
- Top Institutional Investor Stock Rankings